Citadel Advisors »

Gt Biopharma shares owned by Citadel Advisors

Quarter-by-quarter ownership of Gt Biopharma shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Gt Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Gt Biopharma held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gt Biopharma by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $15k 58k 0.26
2023-03-31 $25k 45k 0.55
2022-06-30 $246k 82k 2.99
2022-03-31 $254k 88k 2.88
2021-12-31 $243k 80k 3.06
2021-09-30 $760k 101k 7.52
2021-06-30 $7.9M 510k 15.46